-
Stem Cells and Cloning: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Are reviewers obstructing stem cell research?
Other
(2094) Views (690) Full article downloads
Authors: Bernard Binetruy
Published Date August 2010
Volume 2010:3 Pages 103 - 104
DOI: http://dx.doi.org/10.2147/SCCAA.S13491
Bernard BinetruyINSERM U626, Faculté de Médecine La Timone, Marseille, France
A current controversy in stem cell research was published on the BBC website recently. Some stem cell researchers have said that "they believe a small group of scientists is effectively vetoing high quality science from publication in journals". They strongly suspected some reviewers to be deliberately sending back negative comments or asking for unnecessary experiments. Nature editor, Dr Philip Campbell, has said that "this idea is utterly false".
Readers of this article also read:
Induced pluripotent stem cells: advances to applications
Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Hematopoietic stem cell transplantation
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Erratum
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- DataGenno: building a new tool to bridge molecular and clinical genetics
- Congenital malformations in Ecuadorian children: urgent need to create a National Registry of Birth Defects
- Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine
- Stem cell horizons in intervertebral disc degeneration




